{
    "eid": "2-s2.0-85079338684",
    "title": "The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials",
    "cover-date": "2020-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Api Chewcharat",
        "Pol Chewcharat",
        "Anawin Rutirapong",
        "Stefania Papatheodorou"
    ],
    "citedby-count": 19,
    "ref-count": 44,
    "ref-list": [
        "Update on diabetic nephropathy: Core curriculum 2018",
        "Global and societal implications of the diabetes epidemic",
        "Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study",
        "Diabetic nephropathy: The proteinuria hypothesis",
        "Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease",
        "Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population",
        "Impact of microalbuminuria on incident stroke: A meta-analysis",
        "High serum uric acid as a novel risk factor for type 2 diabetes: Response to Dehghan et al",
        "Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism",
        "Omega-3 fatty acids and inflammatory processes: From molecules to man",
        "Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: A meta-analysis",
        "Omega-3 polyunsaturated fatty acids for the treatment of IgA nephropathy",
        "Placebo-controlled randomized clinical trial of fish oil\u2019s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus",
        "Omega-3 in SLE: A double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus",
        "Evaluating the therapeutic value of omega-3 polyunsaturated fatty acid supplementation on polycystic kidney disease and co-morbidities",
        "Omega-3 fatty acids (fish oil) supplementation and albuminuria: Not a slam dunk",
        "The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: Meta-analysis of clinical trials",
        "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement",
        "Rob 2: A revised tool for assessing risk of bias in randomised trials",
        "Meta-analysis in clinical trials",
        "Measuring inconsistency in meta-analyses",
        "Publication bias in clinical research",
        "Eicosapentaenoic and docosahexaenoic acids attenuate progression of albuminuria in patients with type 2 diabetes mellitus and coronary artery disease",
        "The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: Results of the GO-FISH trial",
        "Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria",
        "Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics",
        "N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination",
        "Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients",
        "Fish oil in diabetic nephropathy",
        "Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria",
        "Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester",
        "Effect of omega-3 fatty acid on the fatty acid content of the erythrocyte membrane and proteinuria in patients with diabetic nephropathy",
        "Fish oil in lupus nephritis: Clinical findings and methodological implications",
        "Pathogenesis of diabetic nephropathy",
        "Diabetic kidney disease: Pathophysiology and therapeutic targets",
        "Diabetic nephropathy: Diagnosis, prevention, and treatment",
        "Regression of microalbuminuria in type 1 diabetes",
        "Patterns of estimated glomerular filtration rate decline leading to end-stage renal disease in type 1 diabetes",
        "Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: A meta-analysis and meta-regression of randomized controlled trials",
        "Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: A meta-analysis of prospective studies",
        "Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: A meta-analysis",
        "Omega-3 fatty acids for the management of hypertriglyceridemia: A science advisory from the American Heart Association",
        "Omega-3 fatty acids EPA and DHA: Health benefits throughout life",
        "Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA"
    ],
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "@id": "60032499",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}